Global Non-Small Cell Lung Cancer Epidemiology and Patient Flow Analysis - 2018

  • ID: 4516294
  • Report
  • Region: Global
  • Fore Pharma
20 % OFF
until Dec 31st 2018
1 of 3
The researcher announced the results of its Non-Small Cell Lung Cancer patients study in a new research ‘Global Non-Small Cell Lung Cancer Epidemiology and Patient Flow Analysis - 2018’. The research provides insights into Non-Small Cell Lung Cancer epidemiology, Non-Small Cell Lung Cancer diagnosed patients, and Non-Small Cell Lung Cancer treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of Non-Small Cell Lung Cancer derived from epidemiological analysis, patients diagnosed with Non-Small Cell Lung Cancer, and patients treated with a drug therapy.

The research study helps executives estimate Non-Small Cell Lung Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Non-Small Cell Lung Cancer prevalence, Non-Small Cell Lung Cancer diagnosis rate, and Non-Small Cell Lung Cancer treatment rate for the period 2017 - 2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.

Key Features of the Report:
  • Non-Small Cell Lung Cancer Patient Flow
  • Non-Small Cell Lung Cancer Prevalence
  • Non-Small Cell Lung Cancer Diagnosed Patients
  • Non-Small Cell Lung Cancer Treated Patients
Note: Product cover images may vary from those shown
2 of 3
1. Non-Small Cell Lung Cancer: Disease Definition
2. Global Non-Small Cell Lung Cancer Patient Flow
2A. Global Non-Small Cell Lung Cancer Prevalence
2B. Global Non-Small Cell Lung Cancer Diagnosed Patients
2C. Global Non-Small Cell Lung Cancer Treated Patients
3. Non-Small Cell Lung Cancer Patient Flow in the US
3A. Non-Small Cell Lung Cancer Prevalence in the US
3B. Non-Small Cell Lung Cancer Diagnosed Patients in the US
3C. Non-Small Cell Lung Cancer Treated Patients in the US
4. Non-Small Cell Lung Cancer Patient Flow in Europe
4A. Non-Small Cell Lung Cancer Prevalence in Europe
4B. Non-Small Cell Lung Cancer Diagnosed Patients in Europe
4C. Non-Small Cell Lung Cancer Treated Patients in Europe
5. Non-Small Cell Lung Cancer Patient Flow in Germany
5A. Non-Small Cell Lung Cancer Prevalence in Germany
5B. Non-Small Cell Lung Cancer Diagnosed Patients in Germany
5C. Non-Small Cell Lung Cancer Treated Patients in Germany
6. Non-Small Cell Lung Cancer Patient Flow in France
6A. Non-Small Cell Lung Cancer Prevalence in France
6B. Non-Small Cell Lung Cancer Diagnosed Patients in France
6C. Non-Small Cell Lung Cancer Treated Patients in France
7. Non-Small Cell Lung Cancer Patient Flow in Spain
7A. Non-Small Cell Lung Cancer Prevalence in Spain
7B. Non-Small Cell Lung Cancer Diagnosed Patients in Spain
7C. Non-Small Cell Lung Cancer Treated Patients in Spain
8. Non-Small Cell Lung Cancer Patient Flow in Italy
8A. Non-Small Cell Lung Cancer Prevalence in Italy
8B. Non-Small Cell Lung Cancer Diagnosed Patients in Italy
8C. Non-Small Cell Lung Cancer Treated Patients in Italy
9. Non-Small Cell Lung Cancer Patient Flow in UK
9A. Non-Small Cell Lung Cancer Prevalence in UK
9B. Non-Small Cell Lung Cancer Diagnosed Patients in UK
9C. Non-Small Cell Lung Cancer Treated Patients in UK
10. Non-Small Cell Lung Cancer Patient Flow in Japan
10A. Non-Small Cell Lung Cancer Prevalence in Japan
10B. Non-Small Cell Lung Cancer Diagnosed Patients in Japan
10C. Non-Small Cell Lung Cancer Treated Patients in Japan
11. Research Methodology

List of Tables
Table 1: Global Non-Small Cell Lung Cancer Patient Flow, 2017
Table 2: Global Non-Small Cell Lung Cancer Patient Flow Forecast, 2017 - 2026
Table 3: Non-Small Cell Lung Cancer Patient Flow in the US, 2017
Table 4: Non-Small Cell Lung Cancer Patient Flow Forecast in the US, 2017 - 2026
Table 5: Non-Small Cell Lung Cancer Patient Flow in Europe, 2017
Table 6: Non-Small Cell Lung Cancer Patient Flow Forecast in Europe, 2017 - 2026
Table 7: Non-Small Cell Lung Cancer Patient Flow in Germany, 2017
Table 8: Non-Small Cell Lung Cancer Patient Flow Forecast in Germany, 2017 - 2026
Table 9: Non-Small Cell Lung Cancer Patient Flow in France, 2017
Table 10: Non-Small Cell Lung Cancer Patient Flow Forecast in France, 2017 - 2026
Table 11: Non-Small Cell Lung Cancer Patient Flow in Spain, 2017
Table 12: Non-Small Cell Lung Cancer Patient Flow Forecast in Spain, 2017 - 2026
Table 13: Non-Small Cell Lung Cancer Patient Flow in Italy, 2017
Table 14: Non-Small Cell Lung Cancer Patient Flow Forecast in Italy, 2017 - 2026
Table 15: Non-Small Cell Lung Cancer Patient Flow in UK, 2017
Table 16: Non-Small Cell Lung Cancer Patient Flow Forecast in UK, 2017 - 2026
Table 17: Non-Small Cell Lung Cancer Patient Flow in Japan, 2017
Table 18: Non-Small Cell Lung Cancer Patient Flow Forecast in Japan, 2017 - 2026

List of Figures
Figures 1: Global Non-Small Cell Lung Cancer Patient Flow, 2017
Figure 2: Global Non-Small Cell Lung Cancer Patient Flow Forecast, 2017 - 2026
Figure 3: Non-Small Cell Lung Cancer Patient Flow in the US, 2017
Figure 4: Non-Small Cell Lung Cancer Patient Flow Forecast in the US, 2017 - 2026
Figure 5: Non-Small Cell Lung Cancer Patient Flow in Europe, 2017
Figure 6: Non-Small Cell Lung Cancer Patient Flow Forecast in Europe, 2017 - 2026
Figure 7: Non-Small Cell Lung Cancer Patient Flow in Germany, 2017
Figure 8: Non-Small Cell Lung Cancer Patient Flow Forecast in Germany, 2017 - 2026
Figure 9: Non-Small Cell Lung Cancer Patient Flow in France, 2017
Figure 10: Non-Small Cell Lung Cancer Patient Flow Forecast in France, 2017 - 2026
Figure 11: Non-Small Cell Lung Cancer Patient Flow in Spain, 2017
Figure 12: Non-Small Cell Lung Cancer Patient Flow Forecast in Spain, 2017 - 2026
Figure 13: Non-Small Cell Lung Cancer Patient Flow in Italy, 2017
Figure 14: Non-Small Cell Lung Cancer Patient Flow Forecast in Italy, 2017 - 2026
Figure 15: Non-Small Cell Lung Cancer Patient Flow in UK, 2017
Figure 16: Non-Small Cell Lung Cancer Patient Flow Forecast in UK, 2017 - 2026
Figure 17: Non-Small Cell Lung Cancer Patient Flow in Japan, 2017
Figure 18: Non-Small Cell Lung Cancer Patient Flow Forecast in Japan, 2017 - 2026
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll